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Abstract
Virulence and persistence in the BALB/c mouse gut was tested for 32 strains of Salmonella enterica for which genome
sequencing is complete or underway, including 17 serovars within subspecies I (enterica), and two representatives of each of
the other five subspecies. Only serovar Paratyphi C strain BAA1715 and serovar Typhimurium strain 14028 were fully virulent
in mice. Three divergent atypical Enteritidis strains were not virulent in BALB/c, but two efficiently persisted. Most of the
other strains in all six subspecies persisted in the mouse intestinal tract for several weeks in multiple repeat experiments
although the frequency and level of persistence varied considerably. Strains with heavily degraded genomes persisted very
poorly, if at all. None of the strains tested provided immunity to Typhimurium infection. These data greatly expand on the
known significant strain-to-strain variation in mouse virulence and highlight the need for comparative genomic and
phenotypic studies.
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Introduction
Salmonella is a pathogen of worldwide importance, causing
disease in a vast range of hosts including humans. There are two
species of Salmonella, S. bongori and S. enterica. S. enterica is comprised
of six subspecies and over 2500 serovars [1] (Figure 1). There are
over 1500 serovars within S. enterica subspecies enterica (also known
as subspecies I) which cause ninety-nine percent of Salmonella
infections in humans [2]. Some serovars within this subspecies
such as Typhi and Paratyphi A, B, and C cause typhoid and
paratyphoid fever, respectively, in humans. Symptoms of typhoid
fever include headache, low to high-grade fever, nausea, lethargy,
myalgia, cough, and weight loss [3]. The symptoms of paratyphoid
fever may be indistinguishable from typhoid fever, except that they
tend to be milder [3]. Other serovars such as Typhimurium and
Enteritidis cause a self-limiting enteritis as well as more severe
disease and even death in young children, the elderly or people
with other diseases such as AIDS or malaria [4,5]. The other five
subspecies of S. enterica are more commonly associated with reptiles
and amphibians and rare cases of human infection are often
associated with eating or keeping reptiles as pets (Reviewed in [6–
8]). The advent of comparative genomics has provided a new
method of identifying genes involved in host range and
pathogenesis. The first step towards this goal is to determine the
spectrum of phenotypes of Salmonella in host infection. The
genomes of hundreds of different isolates of Salmonella enterica are
being sequenced. Among strains with completed and near
completed genomes are two or more representatives of all six
subspecies of Salmonella enterica.
To assay Salmonella strains for virulence we chose as our initial
model a host that was likely to be susceptible to Salmonella
infection. Some mouse strains, those mutated at the slc11A1 locus
(formerly known as Nramp1) such as BALB/c and C57/BL6 [9],
present with a typhoid-like disease when infected with Typhimur-
ium and some other serovars. Mouse lines that are slc11A1+ are
typically resistant to infection, but have proven to be important for
investigating long-term persistence in the mouse, both in the
intestine and the gallbladder [10–18]. Persistence is relevant
because it occurs widely among salmonellae in a variety of
animals, and it propagates the fecal-oral route of transmission. In
this report, 32 Salmonella strains with completed or nearly
completed genome sequences were screened for virulence and
persistence in BALB/c mice. This work will facilitate future
comparative genomic studies between the subspecies and serovars
of Salmonella.
Results
Mouse virulence assays
Groups of BALB/c mice were orally inoculated with approx-
imately 10
9 colony forming units (CFU) of each Salmonella strain,
and their health was monitored daily. The mice were euthanized if
they met any early removal criteria (ERC - lethargy, hunched
posture, or ruffled coat). Our laboratory strain, S. enterica
subspecies enterica serovar Typhimurium strain ATCC14028
(14028), served as a virulent control. Only one other strain,
serovar Paratyphi C BAA1715, was fully virulent, causing all mice
to meet ERC in three separate experiments (Table S1). We
calculated the oral LD50 for Paratyphi C strain BAA1715 in mice
to be 1.6610
5 CFU, which is close to the oral LD50 that was
calculated for the Typhimurium strain 14028 (4.5610
5). One of
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(Table S1).
Fecal shedding and assessment of cross-protection
Only two of the 32 Salmonella strains studied in this report were
fully mouse-virulent, but many of them were capable of
colonizing the mouse intestine for several weeks. In each of the
above experiments, fecal samples were collected from surviving
mice toward the end of the study (between 14 and 23 days post-
infection in the first experiment, at day 14 in the second
experiment and between days 17 and 19 in the third experiment).
In the first two experiments, the presence or absence of Salmonella
in the feces was noted (Table S1 and Figure 2), while in the third
experiment the number of Salmonella in the feces was quantitated
(Table S1 and Figure 2). Although there was a lot of variability,
the strains clearly differed in their ability to colonize the mice and
to be shed in feces.
Avirulent Salmonella strains may exist that provide protection
against virulent strains. These would be candidates for live vaccine
strains. Therefore, at the end of each virulence experiment, all
surviving mice were challenged intragastrically with 1610
9 CFU
of serovar Typhimurium strain 14028. None of the Salmonella
strains provided protection against 14028.
Discussion
Among the 32 strains tested in this report only Typhimurium
strain 14028 and Paratyphi C strain BAA1715 were fully virulent
in mice. The oral LD50 for 14028 and BAA1715 were 4.5610
5
and 1.6610
5 CFU, respectively. While this particular strain of
Paratyphi C had not been tested prior to this study, other strains of
Paratyphi C have been shown to cause disease in mice [19–25].
However, the strains we tested from some serovars previously
reported to be virulent in mice (Abortusovis, Enteritidis, and
Montevideo, see references in Table S1) were not found to be
virulent in this study. The reason for the avirulence of the
Abortusovis and Montevideo isolates is unknown. However, two of
the Enteritidis strains studied here, BAA1587 and BAA1734, were
selected because their genomes differ markedly from the main
Enteritidis clade, and they represent very rare genomovars of this
serotype. Their inability to kill mice is therefore not surprising.
The reason(s) for the discrepancies in virulence between individual
strains of particular serovars or subspecies can be due to genetic
variations between strains that belong to the same serotype but
differ in phylogeny. Porwollik et. al. demonstrated that there can
be hundreds of genes differing between isolates of a single serovar
[28].
The third avirulent strain of Enteritidis, BAA1714, was the
earliest isolated strain of Enteritidis available to us. This strain was
isolated from a guinea pig in 1948, prior to Enteritidis becoming
widespread in chickens and a danger to humans [26,27]. Thus, it
is possible that this strain has lost virulence during its 60 years of
storage or is not the lineage that expanded in chickens and proved
to be pathogenic to humans. In this study, serovar Stanley led to
the death of one out of 13 total mice tested. Serovar Stanley has
not previously been reported to be virulent in mice although it has
been isolated from rats and is a human pathogen [29–34].
Serovars Thompson, Poona, Paratyphi A, and Infantis have never
been shown to cause disease in mice, consistent with the results in
this study, but they have been isolated from wild mice and rats
[35,36] and from laboratory mice [37]. Consistent with this, we
observed that our isolates of Thompson, Poona, and Infantis were
recovered from feces two to three weeks after inoculation.
However, Paratyphi A was not. The genes required for these
strains to colonize the intestinal tract are not known but could be
the focus of future studies. Additionally, serovars Typhimurium,
Enteritidis, Anatum and California were commonly isolated from
laboratory mice in the days before Specific Pathogen Free
certifications [37].
In reviewing the literature (Table S1) we found that some strains
that belong to human-restricted serotypes have been isolated
from peculiar places. One study reported that serovar Typhi
had been isolated from camels in the United Arab Emirates and
Ethiopia (none of the animals presented symptoms) [38,39].
Another study suggested grey duiker antelope as a possible
reservoir for S. Typhi, as individuals who worked as bushmeat
processors were seropositive for S. Typhi. No attempt was made
to isolate S. Typhi from the grey duiker antelope, but the
animals were seropositive for S. Typhi [40]. In 1977, Lavergne
et. al. developed an asymptomatic carrier model in guinea pigs
via a surgically cannulated gall bladder, and Typhi could be
isolated from the bile and feces for up to five months post-
infection [41]. It was later shown that Typhi could cause
systemic infection by a more natural oral infection in newborn
guinea pigs [42]. While the strains of Typhi and Paratyphi A
that we tested in this experiment were not virulent in mice, an
older report shows that isolates of these serovars, which had
been isolated from the heart blood of a dead hen and rabbit,
respectively, were able to kill laboratory mice [43]. Whether or
not the host-restricted strains can truly colonize these animals is
not known, as there have not been repeated animal isolations or
experimental confirmations. In contrast, the serovars that are
considered to have a broad host-range, such as Typhimurium
and Enteritidis, have been repeatedly isolated from up to forty
host organisms. Table S1 exemplifies the ubiquitous nature of
broad host-range Salmonella.
This work demonstrates that significant variations in pathoge-
nicity can occur between strains of Salmonella that, according to
serovar classification, are closely related. These results reinforce
the need for strain genome sequencing, and suggest the need for
additional genomovar classification of Salmonella strains. Further-
more, the fact that strains of the same serovar can vary
significantly in pathogenesis within the same host highlights the
possibility of identifying virulence factors using comparative
genomics.
Figure 1. The Salmonella groups tested for virulence in the
BALB/c mouse model. Representatives of each of the six subspecies
of Salmonella enterica and 17 serovars within subspecies enterica were
tested for virulence in mice. Salmonella bongori was not tested.
doi:10.1371/journal.pone.0036043.g001
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Ethics statement
This study was performed in strict accordance with animal use
protocols approved by The Ohio State University Institutional
Animal Care and Use Committee (IACUC, protocol number
OSU 2009A0035). Mice were euthanized if they met any early
removal criteria (lethargy, hunched posture, or ruffled coat) to
limit suffering.
Bacterial strains and media
All Salmonella strains used in this study are listed in Table 1.
Salmonellae were grown with shaking in Luria-Bertani (LB) broth
at 37uC (EMD Chemicals, Gibbstown, NJ).
Mouse virulence and fecal shedding
Female BALB/c mice (8 to 10 weeks old) were obtained from
Harlan laboratories. Overnight cultures of each Salmonella strain
were centrifuged at 50006g and resuspended in fresh LB broth
and kept on melting ice. Mice were inoculated intragastrically with
0.2 ml of each Salmonella strain (approximately 10
9 total CFU), and
dilution plating of each inoculum was used to determine the actual
dose administered.
Xylose-lysine-desoxycholate (XLD) agar (EMD Chemicals)
plates were used for the recovery of Salmonella from feces. Fecal
pellets from surviving mice were homogenized and dilution plated
for enumeration. Surviving mice were challenged with 10
9 CFU of
14028 to assess if immunity was elicited by any test strains.
LD50 determinations
Inocula of 14028 and Paratyphi C strain BAA1715 were
prepared as described above. The suspensions were serially diluted
in LB broth and groups of five mice were inoculated with doses
ranging from 10
1 to 10
9 CFU. Mice meeting ERC were
euthanized. The LD50 was calculated using the method of Reed
and Muench [44].
Figure 2. Salmonella recovery and persistence in the feces. The left panel shows a cladogram that was inferred from core-genome SNPS using
Maximum Parsimony. All positions containing gaps and missing data were eliminated. There were a total of 344642 positions of which 279065 were
parsimony informative. The parsimony analysis was conducted using Mega5 [45]. The middle panel shows Salmonella recovery from feces of
surviving mice at 17 and 19 days post-infection. Dots represent individual measurements and the vertical line represents the median. The dotted line
represents the 100 CFU/gm detection limit. The right panel represents the proportion of mice that were persistently infected with Salmonella. Black
bars indicate that all mice met ERC. *One mouse met the ERC and was euthanized before the experiment was completed.
doi:10.1371/journal.pone.0036043.g002
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Table S1
a Current American Type Culture Collection
(ATCC) strain numbers,
b subspecies or serovar name,
c
specific strain collections if applicable,
d number of
mice meeting ERC out of the total tested in three
different experiments,
e number of mice that had
Salmonella in feces between 14 and 23 days post-
infection in the first experiment, at day 14 in the second
experiment and between days 17 and 19 in the third
experiment. In the first two experiments the presence/absence
call had a detection limit of 100 CFU,
f information about sources,
antigenic formulae, electrophoretic types, and strain aliases, and
g
a literature review of the animal sources or models for the
salmonellae tested. Abbreviations: Salmonella genetic stock center
(SGSC), Salmonella reference collection B and C (SARB and
SARC, respectively), year (yr.) years old (y), accession number
(Acc:), chromosome (chro), plasmid (plsm), and Center for Disease
Control (CDC). * denotes virulence; ** denotes laboratory model;
*** denotes isolation but not necessarily virulence, ****denotes
seropositive.
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